Virginia Universities Launch Neuropathy Research Project
George Mason and Virginia Commonwealth University receive grant funding to study nerve pain in cancer survivors.
Updated on Oct. 25, 2026 in Cancer
Live Poll
Should medical research funding prioritize improving long-term quality of life for cancer survivors?
George Mason University and Virginia Commonwealth University have launched a new research collaboration focused on chemotherapy-induced peripheral neuropathy. The project is specifically designed to improve understanding of this condition among breast cancer survivors.
Why it matters
Peripheral neuropathy is a common and debilitating side effect for many patients undergoing chemotherapy. This research aims to provide critical insights that could eventually lead to better management and treatment strategies for survivors dealing with long-term nerve pain.
The Commonwealth Health Research Board has provided a $200,000 grant to support this collaborative study. The research focuses exclusively on chemotherapy-induced peripheral neuropathy within the breast cancer survivor population.
The players
Nadine Kabbani
A researcher at George Mason University who is serving as a project lead for the peripheral neuropathy study.
Imad Damaj
A lead researcher from Virginia Commonwealth University involved in the collaborative study on nerve pain.
Paula Bos
A lead researcher based at the VCU Massey Comprehensive Cancer Center who is coordinating efforts on the new project.
Commonwealth Health Research Board
A state-level organization that facilitates funding for medical and health research initiatives across Virginia.
The details
The project represents a joint effort between researchers at George Mason University and Virginia Commonwealth University, including experts from the VCU Massey Comprehensive Cancer Center. Teams are working to identify the mechanisms behind nerve damage caused by cancer treatment to better support patient recovery.
Timeline
The research collaboration was officially announced on October 25, 2026.
The Big Picture
The study builds upon the existing clinical infrastructure at the VCU Massey Comprehensive Cancer Center to address long-term survivorship challenges. This collaboration extends the capacity of regional institutions to provide specialized care for chronic chemotherapy side effects.
This research provides hope for future treatment options for breast cancer survivors currently experiencing chronic nerve pain. Patients may eventually see new clinical protocols or management strategies emerge from these findings to improve their quality of life.
The takeaway
Advancements in understanding chemotherapy side effects are essential to improving the long-term health outcomes of cancer survivors. Patients should continue to discuss new management techniques and ongoing research opportunities with their primary oncology care providers.
Further reading
For more information on ongoing research and advancements in the field, explore the Virginia Cancer section.
Source note: This article includes information reported by Potomac Local News.
Live Poll
Should medical research funding prioritize improving long-term quality of life for cancer survivors?
